WH
Wende Hutton
OtherActiveGeneral Partner at Canaan Partners
16
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Wende Hutton.
Investment Thesis & Strategy
Wende Hutton, as a General Partner at Canaan Partners, invests in various stages of biotech, health & hospital services, health IT, and pharmaceutical companies. They seek to partner with innovative companies that are poised to disrupt the healthcare industry.
Investment Activity
Deals per year over the last 11 years
1
20102
20111
20120
20133
20141
20151
20160
20171
20180
20191
2020Portfolio Companies
Selected investments from their portfolio of 16 companies
M
Minimally invasive devices
Healthcare · Seed, 0
M
Mantra Health
Healthcare · Series A, 2020
A
Apieron
Biotech · Seed, 2018
O
OncoResponse
Biotech · Series A, 2016
H
Hyalex Orthopaedics
Healthcare · Series A, 2015
A
Antiva Biosciences
Biotech · Series A, 2014
B
Butterfly Health
Healthcare · Seed, 2014
L
Labrys Biologics
Biotech · Seed, 2014
C
Calibra Medical
Healthcare · Seed, 2012
D
Dermira
Biotech · Series A, 2011
A
ALDEA Pharmaceuticals
Biotech · Seed, 2011
G
Glooko
Healthcare · Series A, 2010
Frequently Asked Questions
Wende Hutton focuses on Series B, Series A stage investments.